Mackenzie Financial »

Regeneron Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $54M 56k 962.49
2023-12-31 $49M 56k 878.29
2023-09-30 $46M 56k 808.31
2023-06-30 $43M 60k 718.09
2023-03-31 $55M 67k 821.67
2022-12-31 $52M 72k 721.49
2022-09-30 $56M 82k 688.86
2022-06-30 $53M 89k 591.13
2022-03-31 $66M 94k 698.42
2021-12-31 $56M 88k 631.52
2021-09-30 $54M 89k 605.18
2021-06-30 $49M 89k 558.54
2021-03-31 $33M 70k 473.14
2020-12-31 $18M 37k 483.10
2020-09-30 $18M 31k 559.78
2020-06-30 $15M 23k 623.66
2020-03-31 $9.2M 19k 488.30
2019-12-31 $6.8M 18k 375.50
2019-09-30 $956k 3.4k 277.42
2019-06-30 $301k 961 313.22
2019-03-31 $2.8M 6.8k 410.60
2018-12-31 $562k 1.5k 373.67
2018-09-30 $609k 1.5k 403.85
2018-06-30 $443k 1.3k 345.28
2018-03-31 $348k 1.0k 343.87
2017-12-31 $204k 543 375.69